ReviewFrontiers in pediatrics2022

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran.

Maha Al-Ghafry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.